Our scientists engage with you in the design and execution of
your preclinical drug development program using our AAALAC approved animal facilities, proprietary animal models, and extensive capabilities.
CAMBRIDGE, MA and SAN FRANCISCO, CA — The ALS Therapy Development Institute (ALS TDI) and the Gladstone Institutes today announced the formation of a research collaboration to speed the discovery of potential treatments for ALS through
the preclinical drug development process.
Tags for this Online Resume: Business Development, CRO Services, Biologics, Small Molecules,
Preclinical Drug Development, Drug Discovery, In Vivo efficacy models, Preclinical R&D, ELISA, Cardiovascular, Cellular, Injections, Oncology, Research, Pharmaceutical, Business Development Manager, Cancer, Applications, Automation, Field Applications Scientist, Cell based assays